Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.2.959

Clinical Analysis of Stages of HBV Infection in 100 Cases of Lymphoma  

Tang, Yang (Department of Oncology, the First Hospital of Jilin University)
Sun, Li-Guang (School of Translational Medicine, the First Hospital of Jilin University)
Liu, Chun-Shui (Department of Oncology, the First Hospital of Jilin University)
Li, Yu-Ying (Department of Oncology, the First Hospital of Jilin University)
Jin, Chun-Hui (Department of Oncology, the First Hospital of Jilin University)
Li, Dan (Department of Oncology, the First Hospital of Jilin University)
Bai, Ou (Department of Oncology, the First Hospital of Jilin University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.2, 2013 , pp. 959-962 More about this Journal
Abstract
Objective: HBV infection may cause damage to the immune system and induce lymphomas as a result. Some scholars have indicated that HBsAg(+) reflecting HBV infection may have a relationship with lymphoma development. This study was designed to find out the specific stage of HBV infection which may be related to lymphoma. Methods: HBV serum markers, including HBsAg, HBsAb, HBeAg, HBeAb, HBcAb were tested among 100 lymphoma patients and 100 other patients who were diagnosed with non-lymphoma diseases in the First Hospital of Jilin University from 2010.1.1 to 2012.12.31. Three subgroups were established depending on different combinations of HBV serum markers. Subgroup 1 was HBsAg(+) representing the early stage of HBV infection. Subgroup 2 was HbsAb(+) representing convalescence and Subgroup 3 was "HbsAg and HbsAb negative combined with other positive markers" representing the intermediate stage of HBV infection. Chi square tests were used to compare the rates of three subgroups in lymphoma and control groups. Results: The rates of Subgroup were 13% and 5% respectively, an association between HBsAg and lymphoma being found (P<0.05). There was no difference between rate of Subgroup 2 of lymphoma group (15%) and that of control group (16%). In lymphoma group and control group, the rate of Subgroup 3 was different (12% vs 4%). This evidence was not specific to T cell lymphoma, B cell lymphoma or Hodgkin's lymphoma. Conclusions: Among serum markers of HBV, the combination of serum markers representing the early stage and intermediate stage of HBV infection have a relationship with lymphoma. Convalescence from HBV infection appears to have no relationship with lymphoma.
Keywords
Lymphoma; hepatitis B virus; serum markers;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Alexander DD, Mink PJ, Adami HO, et al (2007). The non-Hodgkin lymphomas: a reviewof the epidemiologic literature. Int J Cancer, 120, 1-39.
2 Altman BJ, Dang CV (2012). Normal and cancer cell metabolism: lymphocytes and lymphoma. FEBS J, 279, 2598-609.   DOI   ScienceOn
3 Becker N, Schnitzler P, Boffetta P, et al (2012). Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol, 138, 1993-2001.   DOI   ScienceOn
4 Cucuianu A, Patiu M, Duma M, et al (1999). Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol, 110, 497-8.
5 Elaine SJ (2008). World Health Organization Classification of Tumors and the Diagnostic Criteria. ISBN-13: 9789283224112.
6 Eric AE, Eo RC, Sun HJ, et al (2010). Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol, 11, 827-34.   DOI   ScienceOn
7 Fabrizio M, Enea S, Alfonso M, et al (2012) .The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review. Am J Blood Res, 2, 18-28.
8 Jay HH (2009). Reactivation of Hepatitis B. Hepatology, 49, 156-65.   DOI   ScienceOn
9 Kang J, Cho JH, Suh CW, et al (2011). High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol, 90, 159-64.   DOI   ScienceOn
10 Kathryn T, Michelle SM, Amick AC et al (2010). Epstein-Barr Virus in Burkitt's Lymphoma: a role for Latent Membrane Protein 2A. Cell Cycle, 9, 901-8.   DOI
11 Kim YM, Jeong SH, Kim JW, et al (2011). Chronic hepatitis B, non-Hodgkin's lymphoma,and effect of prophylactic antiviral therapy. J Clin Virol, 51, 237-41.
12 Li J, Han YP, Ke J, et al (2011). Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer(NK) cells, and natural killer T(NKT) cells in patients with acute hepatitis B infection. Virol J, 8, 199.   DOI   ScienceOn
13 Nath A, Agarwal R, Malhotra P, et al (2010). Prevalence of hepatitis B virus infection in non-Hodgkin's lymphoma. A systematic review and meta-analysis. Intern Med J, 125, 1723-32.
14 Mele A, Pulsoni A, Bianco E, et al (2003) . Hepatitis C virus and B cell non- Hodgkin's lymphomas: an Italian multicenter case control study. Blood, 102, 996-9. .   DOI   ScienceOn
15 Michalek RD , Rathmell JC (2010). The metabolic life and times of a T-cell. Immunol Rev, 236, 190-202.   DOI   ScienceOn
16 Chen MH, Hsiao LT, Chiou TJ, et al (2008). High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol, 87, 475-80.   DOI
17 Park SC, Jeong SH, Kim J, et al (2008). High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin lymphoma in Korea. J Med Virol, 80, 960-6.   DOI   ScienceOn
18 Quinn ER, Chan CH, Hadlock KG, et al (2001). The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood, 98, 3745-9.   DOI   ScienceOn
19 Rehermann B, Nascimbeni M (2005) . Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol, 5, 215-29.   DOI   ScienceOn
20 Shankland KR, Armitage JO, Hancock BW et al (2012). Non-Hodgkin lymphoma. Lancet, 380, 848-57.   DOI   ScienceOn
21 Thorley-Lawson DA, Allday MJ (2009). The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol, 2008, 913-24.
22 Tiollais P, Pourcel C, Dejean A (1985). The hepatitis B virus. Nature, 17, 489-95.
23 Ulcickas Yood M, Quesenberry CP (2007). Incidence of non- Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology, 46, 107-12.
24 Wang F, Xu RH, Han B, et al (2007). High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer, 109, 1360-4.   DOI   ScienceOn
25 Wang XQ (2006). Cytogenetic study on 155 cases of non-Hodgkin's lymphoma. Zhonghua Xue Ye Xue Za Zhi, 7, 656-60.
26 Zhu ZZ, Cong WM, Liu SF, et al (2005). A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Cancer Lett, 229, 77-83.   DOI   ScienceOn